Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neurotherapeutics
Published in: Neurotherapeutics 4/2012

01-10-2012

Parasomnias: An Updated Review

Author: Michael J. Howell

Published in: Neurotherapeutics | Issue 4/2012

Login to get access

Abstract

Parasomnias are abnormal behaviors emanating from or associated with sleep. Sleepwalking and related disorders result from an incomplete dissociation of wakefulness from nonrapid eye movement (NREM) sleep. Conditions that provoke repeated cortical arousals, or promote sleep inertia lead to NREM parasomnias by impairing normal arousal mechanisms. Changes in the cyclic alternating pattern, a biomarker of arousal instability in NREM sleep, are noted in sleepwalking disorders. Sleep-related eating disorder (SRED) is characterized by a disruption of the nocturnal fast with episodes of feeding after an arousal from sleep. SRED is often associated with the use of sedative-hypnotic medications; in particular, the widely prescribed benzodiazepine receptor agonists. Recently, compelling evidence suggests that nocturnal eating may in some cases be a nonmotor manifestation of Restless Legs Syndrome (RLS). rapid eye movement (REM) Sleep Behavior Disorder (RBD) is characterized by a loss of REM paralysis leading to potentially injurious dream enactment. The loss of atonia in RBD often predates the development of Parkinson’s disease and other disorders of synuclein pathology. Parasomnia behaviors are related to an activation (in NREM parasomnias) or a disinhibition (in RBD) of central pattern generators (CPGs). Initial management should focus on decreasing the potential for sleep-related injury followed by treating comorbid sleep disorders. Clonazepam and melatonin appear to be effective therapies in RBD, whereas paroxetine has been reported effective in some cases of sleep terrors. At this point, pharmacotherapy for other parasomnias is less certain, and further investigations are necessary.
Appendix
Available only for authorised users
Literature
1.
American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual, 2nd edit. Westchester, IL: American Academy of Sleep Medicine, 2005.
2.
Parrino L, Halasz P, Tassinari CA, Terzano MG. CAP, epilepsy and motor events during sleep: the unifying role of arousal. Sleep Med Rev 2006;10:267–285.PubMed
3.
Guilleminault C, Kirisoglu C, da Rosa AC, Lopes C, Chan A. Sleepwalking, a disorder of NREM sleep instability. Sleep Med 2006;7:163–170.PubMed
4.
Vetrugno R, Manconi M, Ferini-Strambi L, Provini F, Plazzi G, Montagna P. Nocturnal eating: sleep-related eating disorder or night eating syndrome? A videopolysomnographic study. Sleep 2006;29:949–954.PubMed
5.
Howell MJ, Schenck CH, Crow SJ. A review of nighttime eating disorders. Sleep Med Rev 2009 13:23–34.PubMed
6.
Howell MJ, Schenck CH. Restless nocturnal eating: a common feature of Willis-Ekbom Syndrome (RLS). JCSM 2012;8:413–419.
7.
Boeve BF. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010;1184:15–54.PubMed
8.
Schenck CH, Arnulf I, Mahowald MW. Sleep and sex: what can go wrong? A review of the literature on sleep related disorders and abnormal sexual behaviors and experiences. Sleep 2007;30:683–702.PubMed
9.
10.
Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology 1997;48:177–181.PubMed
11.
Ohayon MM, Guilleminault C, Priest RG. Night terrors, sleepwalking, and confusional arousals in the general population: their frequency and relationship to other sleep and mental disorders. J Clin Psychiatry 1999;60:268–276.PubMed
12.
Pires ML, Benedito-Silva AA, Mello MT, Pompeia Sdel G, Tufik S. Sleep habits and complaints of adults in the city of Sao Paulo, Brazil, in 1987 and 1995. Braz J Med Biol Res 2007;40:1505–1515.PubMed
13.
Dolder CR, Nelson MH. Hypnosedative-induced complex behaviours : incidence, mechanisms and management. CNS Drugs 2008;22:1021–1036.PubMed
14.
Espa F, Dauvilliers Y, Ondze B, Billiard M, Besset A. Arousal reactions in sleepwalking and night terrors in adults: the role of respiratory events. Sleep 2002;25:871–875.PubMed
15.
Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics 2003;111:e17-e25.PubMed
16.
Lam SP, Fong SY, Ho CK, Yu MW, Wing YK. Parasomnia among psychiatric outpatients: a clinical, epidemiologic, cross-sectional study. J Clin Psychiatry 2008;69:1374–1382.PubMed
17.
Lam SP, Fong SY, Yu MW, Li SX, Wing YK. Sleepwalking in psychiatric patients: comparison of childhood and adult onset. Aust N Z J Psychiatry 2009;43:426–430.PubMed
18.
Canaday BR. Amnesia possibly associated with zolpidem administration. Pharmacotherapy 1996;16:687–689.PubMed
19.
Fava GA. Amnestic syndrome induced by zoplclone. Eur J Clin Pharmacol 1996;50:509.PubMed
20.
Harazin J, Berigan TR. Zolpidem tartrate and somnambulism. Mil Med 1999;164:669–670.PubMed
21.
Morgenthaler TI, Silber MH. Amnestic sleep-related eating disorder associated with zolpidem. Sleep Med 2002;3:323–327.PubMed
22.
Sattar SP, Ramaswamy S, Bhatia SC, Petty F. Somnambulism due to probable interaction of valproic acid and zolpidem. Ann Pharmacother 2003;37:1429–1433.PubMed
23.
Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. J Am Acad Child Adolesc Psychiatry 2004;43:927–928.PubMed
24.
Kintz P, Villain M, Dumestre-Toulet V, Ludes B. Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS/MS A case involving zolpidem. J Clin Forensic Med 2005;12:36–41.PubMed
25.
Yang W, Dollear M, Muthukrishnan SR. One rare side effect of zolpidem--sleepwalking: a case report. Arch Phys Med Rehabil 2005;86:1265–1266.PubMed
26.
Tsai MJ, Tsai YH, Huang YB. Compulsive activity and anterograde amnesia after zolpidem use. Clin Toxicol (Phila) 2007;45:179–181.
27.
Holm KJ, Goa KL. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 2000;59:865–889.PubMed
28.
Ferrandiz-Santos JA, Mataix-Sanjuan AL. Amitriptyline and somnambulism. Ann Pharmacother 2000;34:1208.PubMed
29.
Khazaal Y, Krenz S, Zullino DF. Bupropion-induced somnambulism. Addict Biol 2003;8:359–362.PubMed
30.
Oulis P, Kokras N, Papadimitriou GN, Masdrakis VG. Bupropion-induced sleepwalking. J Clin Psychopharmacol 2010;30:83–84.PubMed
31.
Kawashima T, Yamada S. Paroxetine-induced somnambulism. J Clin Psychiatry 2003;64:483.PubMed
32.
Yeh YW, Chen CH, Feng HM, Wang SC, Kuo SC, Chen CK. New onset somnambulism associated with different dosage of mirtazapine: a case report. Clin Neuropharmacol 2009;32:232–233.PubMed
33.
Charney DS, Kales A, Soldatos CR, Nelson JC. Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. Br J Psychiatry 1979;135:418–424.PubMed
34.
Landry P, Warnes H, Nielsen T, Montplaisir J. Somnambulistic-like behaviour in patients attending a lithium clinic. Int Clin Psychopharmacol 1999;14:173–175.PubMed
35.
Hafeez ZH, Kalinowski CM. Somnambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr 2007;12:910–912.PubMed
36.
Kolivakis TT, Margolese HC, Beauclair L, Chouinard G. Olanzapine-induced somnambulism. Am J Psychiatry 2001;158:1158.PubMed
37.
Paquet V, Strul J, Servais L, Pelc I, Fossion P. Sleep-related eating disorder induced by olanzapine. J Clin Psychiatry 2002;63:597.PubMed
38.
Chiu YH, Chen CH, Shen WW. Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:581–582.PubMed
39.
Hensel J, Pillmann F. Late-life somnambulism after therapy with metoprolol. Clin Neuropharmacol 2008;31:248–250.PubMed
40.
Varkey BM, Varkey LM. Topiramate induced somnabulism and automatic behaviour. Indian J Med Sci 2003;57:508–510.PubMed
41.
von Vigier RO, Vella S, Bianchetti MG. Agitated sleepwalking with fluoroquinolone therapy. Pediatr Infect Dis J 1999;18:484–485.
42.
Barabas G, Ferrari M, Matthews WS. Childhood migraine and somnambulism. Neurology 1983;33:948–949.PubMed
43.
Casez O, Dananchet Y, Besson G. Migraine and somnambulism. Neurology 2005;65:1334–1335.PubMed
44.
Kales JD, Kales A, Soldatos CR, Chamberlin K, Martin ED. Sleepwalking and night terrors related to febrile illness. Am J Psychiatry 1979;136:1214–1215.PubMed
45.
Mouzas O, Angelopoulos N, Papaliagka M, Tsogas P. Increased frequency of self-reported parasomnias in patients suffering from vitiligo. Eur J Dermatol 2008;18:165–168.PubMed
46.
Ajlouni KM, Ahmad AT, El-Zaheri MM, et al. Sleepwalking associated with hyperthyroidism. Endocr Pract 2005;11:5–10.PubMed
47.
Steriade M, Llinas RR. The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 1988;68:649–742.PubMed
48.
Neckelmann D, Ursin R. Sleep stages and EEG power spectrum in relation to acoustical stimulus arousal threshold in the rat. Sleep 1993;16:467–477.PubMed
49.
Pilon M, Montplaisir J, Zadra A. Precipitating factors of somnambulism: impact of sleep deprivation and forced arousals. Neurology 2008;70:2284–2290.PubMed
50.
Mahowald MW, Schenck CH, Cramer Bornemann MA. Sleep-related violence. Curr Neurol Neurosci Rep 2005;5:153–158.PubMed
51.
Tachibana N, Sugita Y, Terashima K, Teshima Y, Shimizu T, Hishikawa Y. Polysomnographic characteristics of healthy elderly subjects with somnambulism-like behaviors. Biol Psychiatry 1991;30:4–14.PubMed
52.
Zucconi M, Oldani A, Ferini-Strambi L, Smirne S. Arousal fluctuations in non-rapid eye movement parasomnias: the role of cyclic alternating pattern as a measure of sleep instability. J Clin Neurophysiol 1995;12:147–154.PubMed
53.
Schenck CH, Pareja JA, Patterson AL, Mahowald MW. Analysis of polysomnographic events surrounding 252 slow-wave sleep arousals in thirty-eight adults with injurious sleepwalking and sleep terrors. J Clin Neurophysiol 1998;15:159–166.PubMed
54.
Espa F, Ondze B, Deglise P, Billiard M, Besset A. Sleep architecture, slow wave activity, and sleep spindles in adult patients with sleepwalking and sleep terrors. Clin Neurophysiol 2000;111:929–939.PubMed
55.
Guilleminault C, Kirisoglu C, Bao G, Arias V, Chan A, Li KK. Adult chronic sleepwalking and its treatment based on polysomnography. Brain 2005;128:1062–1069.PubMed
56.
Busek P, Vankova J, Opavsky J, Salinger J, Stepanova I, Nevsimalova S. Spectral analysis of the variations in heart rate and cardiac activation on waking up in sleepwalking. Rev Neurol 2005;41:338–343.PubMed
57.
Gaudreau H, Joncas S, Zadra A, Montplaisir J. Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep 2000;23:755–760.PubMed
58.
Jacobson A, Kales A, Lehmann D, ZWEIZIG JR. Somnambulism: all-night electroencephalographic studies. Science 1965;48:975–977.
59.
Guilleminault C, Poyares D, Aftab FA, Palombini L. Sleep and wakefulness in somnambulism: a spectral analysis study. J Psychosom Res 2001;51:411–416.PubMed
60.
Guilleminault C. Hypersynchronous slow delta, cyclic alternating pattern and sleepwalking. Sleep 2006;29:14–15.PubMed
61.
Zadra A, Pilon M, Joncas S, Rompre S, Montplaisir J. Analysis of postarousal EEG activity during somnambulistic episodes. J Sleep Res 2004;13:279–284.PubMed
62.
Terzano MG, Parrino L. Origin and significance of the cyclic alternating pattern (cap). Sleep Med Rev 2000;4:101–123.PubMed
63.
Guilleminault C, Lee JH, Chan A, Lopes MC, Huang YS, da Rosa A. Non-REM-sleep instability in recurrent sleepwalking in pre-pubertal children. Sleep Med 2005;6:515–521.PubMed
64.
Terzaghi M, Sartori I, Tassi L, et al. Evidence of dissociated arousal states during NREM parasomnia from an intracerebral neurophysiological study. Sleep 2009;32:409–412.PubMed
65.
Bassetti C, Vella S, Donati F, Wielepp P, Weder B. SPECT during sleepwalking. Lancet 2000;356:484–485.PubMed
66.
Van Cauter E, Polonsky KS, Scheen AJ. Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997;18:716–738.PubMed
67.
Schenck CH, Connoy DA, Castellanos M, Johnson B, Wills L, Cramer-Bornemann MA, Mahowald MW. Zolpidem-induced Sleep-Related Eating Disorder (SRED) in 19 patients. Sleep 2005;28(supplement):a259.
68.
Schenck CH, Hurwitz TD, Bundlie SR, Mahowald MW. Sleep-related eating disorders: polysomnographic correlates of a heterogeneous syndrome distinct from daytime eating disorders. Sleep 1991;14:419–431.PubMed
69.
Winkelman JW. Clinical and polysomnographic features of sleep-related eating disorder. J Clin Psychiatry 1998;59:14–19.PubMed
70.
Winkelman JW, Herzog DB, Fava M. The prevalence of sleep-related eating disorder in psychiatric and non-psychiatric populations. Psychol Med 1999;29:1461–1466.PubMed
71.
Provini F, Antelmi E, Vignatelli L, et al. Association of restless legs syndrome with nocturnal eating: a case–control study. Mov Disord 2009;24:871–877.PubMed
72.
Schenck CH, Mahowald MW. Review of nocturnal sleep-related eating disorders. Int J Eat Disord 1994;15:343–356.PubMed
73.
Schenck CH. Paradox Lost: midnight in the battleground of sleep and dreams, 1st edit. Extreme-Nights, LLC, 2006.
74.
Nadel C. Somnambulism, bed-time medication and over-eating. Br J Psychiatry 1981;139:79.PubMed
75.
Lu ML, Shen WW. Sleep-related eating disorder induced by risperidone. J Clin Psychiatry 2004;65:273–274.PubMed
76.
Molina SM, Joshi KG. A case of zaleplon-induced amnestic sleep-related eating disorder. J Clin Psychiatry 2010;71:210–211.PubMed
77.
Najjar M. Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med 2007;3:637–638.PubMed
78.
Chiang A, Krystal A. Report of two cases where sleep related eating behavior occurred with the extended-release formulation but not the immediate-release formulation of a sedative-hypnotic agent. J Clin Sleep Med 2008;4:155–156.PubMed
79.
Sansone RA, Sansone LA. Zolpidem, somnambulism, and nocturnal eating. Gen Hosp Psychiatry 2008;30:90–91.PubMed
80.
Dang A, Garg G, Rataboli PV. Zolpidem induced nocturnal sleep-related eating disorder (NSRED) in a male patient. Int J Eat Disord 2009;42:385–386.PubMed
81.
Valiensi SM, Cristiano E, Martinez OA, Reisin RC, Alvarez F. Sleep related eating disorders as a side effect of zolpidem]. Medicina (B Aires) 2010;70:223–226.
82.
Wing YK, Lam SP, Li SX, Zhang J, Yu MW. Sleep-related eating disorder and zolpidem: an open interventional cohort study. J Clin Psychiatry 2010;71:653–656.PubMed
83.
Hwang TJ, Ni HC, Chen HC, Lin YT, Liao SC. Risk predictors for hypnosedative-related complex sleep behaviors: a retrospective, cross-sectional pilot study. J Clin Psychiatry 2010;71:1331–1335.PubMed
84.
de Zwaan M, Roerig DB, Crosby RD, Karaz S, Mitchell JE. Nighttime eating: a descriptive study. Int J Eat Disord 2006;39:224–232.PubMed
85.
Whyte J KN. Somnambulistic eating: A report of three cases. Int J Eat Disord 1990;9:577–581.
86.
Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004;164:196–202.PubMed
87.
Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286–1292.PubMed
88.
Paulus W, Dowling P, Rijsman R, Stiasny-Kolster K, Trenkwalder C. Update of the pathophysiology of the restless-legs-syndrome. Mov Disord 2007;22(suppl 18):S431-S439.PubMed
89.
Bello NT, Hajnal A. Dopamine and binge eating behaviors. Pharmacol Biochem Behav 2010;97:25–33.PubMed
90.
Lavigne GJ, Kato T, Kolta A, Sessle BJ. Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 2003;14:30–46.PubMed
91.
Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 1994;17:739–743.PubMed
92.
Manni R, Ratti MT, Tartara A. Nocturnal eating: prevalence and features in 120 insomniac referrals. Sleep 1997;20:734–738.PubMed
93.
Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995 ;10:634–642.PubMed
94.
Provini F, Antelmi E, Vignatelli L, Zaniboni A, Naldi G, Calandra-Buonaura G, et al. Increased prevalence of nocturnal smoking in restless legs syndrome (RLS). Sleep Med 2010;11:218–220.PubMed
95.
Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524–529.PubMed
96.
Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 2007;21:501–506.PubMed
97.
Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007;30:249–255.PubMed
98.
Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007;68:301–303.PubMed
99.
Nirenberg MJ, Waters C. Nocturnal eating in restless legs syndrome. Mov Disord 2010;25:126–127.PubMed
100.
Martin-Iverson MT, Dourish CT. Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology (Berl) 1988;96:370–374.
101.
Schenck CH, Mahowald MW. Combined buproprion-levodopa-trazadone therapy of sleep-related eating disorder and sleep disruption in two adults with chemical dependency. Sleep 2000;23:587–588.PubMed
102.
Provini F, Albani F, Vetrugno R, et al. A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. Eur J Neurol 2005;12:432–436.PubMed
103.
Yun CH, Ji KH. Zolpidem-induced sleep-related eating disorder. J Neurol Sci 2010;288:200–201.PubMed
104.
Mahowald MW, Cramer Bornemann MA, Schenck CH. A case of reversible restless legs syndrome (RLS) and sleep-related eating disorder relapse triggered by acute right leg herpes zoster infection: literature review of spinal cord and peripheral nervous system contributions to RLS. Sleep Med 2010;11:583–585.PubMed
105.
Schenck CH, Lee SA, Bornemann MA, Mahowald MW. Potentially lethal behaviors associated with rapid eye movement sleep behavior disorder: review of the literature and forensic implications. J Forensic Sci 2009;54:1475–1484.PubMed
106.
Nielsen T, Svob C, Kuiken D. Dream-enacting behaviors in a normal population. Sleep 2009;32:1629–1636.PubMed
107.
Nielsen T, Paquette T. Dream-associated behaviors affecting pregnant and postpartum women. Sleep 2007;30:1162–1169.PubMed
108.
Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry 1997;58:369–376.PubMed
109.
Chiu HF, Wing YK, Chung DW, Ho CK. REM sleep behaviour disorder in the elderly. Int J Geriatr Psychiatry 1997;12:888–891.PubMed
110.
Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61:40–45.PubMed
111.
Dauvilliers Y, Rompre S, Gagnon JF, Vendette M, Petit D, Montplaisir J. REM sleep characteristics in narcolepsy and REM sleep behavior disorder. Sleep 2007;30:844–849.PubMed
112.
Ozekmekci S, Apaydin H, Kilic E. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005;107:306–309.PubMed
113.
Ju YE, Larson-Prior L, Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med 2011;12:278–283.PubMed
114.
Bodkin CL, Schenck CH. Rapid eye movement sleep behavior disorder in women: relevance to general and specialty medical practice. J Womens Health (Larchmt) 2009;18:1955–1963.
115.
Fantini ML, Corona A, Clerici S, Ferini-Strambi L. Aggressive dream content without daytime aggressiveness in REM sleep behavior disorder. Neurology 2005;65:1010–1015.PubMed
116.
Schenck CH MM. Does REM sleep behavior disorder protect against obstructive sleep apnea? 1992;21:257.
117.
Huang J, Zhang J, Lam SP, et al. Amelioration of obstructive sleep apnea in REM sleep behavior disorder: implications for the neuromuscular control of OSA. Sleep 2011;34:909–915.PubMed
118.
Lai YY, Siegel JM. Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder. Mol Neurobiol 2003;27:137–152.PubMed
119.
Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009;13:385–401.PubMed
120.
Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845–851.PubMed
121.
Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology 2004;62:41–45.PubMed
122.
Terzaghi M, Sinforiani E, Zucchella C, et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Med 2008;9:343–351.PubMed
123.
Fantini ML, Farini E, Ortelli P, et al. Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep 2011;34:619–625.PubMed
124.
Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011;69:811–818.PubMed
125.
Sasai T, Miyamoto T, Miyamoto M, et al. Impaired decision-making in idiopathic REM sleep behavior disorder. Sleep Med 2012;13:301–306.PubMed
126.
Massicotte-Marquez J, Décary A, Gagnon J, et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 2008;70:1250–7.PubMed
127.
Stiasny-Kolster K, Doerr Y, Moller JC, et al. Combination of “idiopathic” REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005;128:126–137.PubMed
128.
Fantini ML, Postuma RB, Montplaisir J, Ferini-Strambi L. Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder. Brain Res Bull 2006;70:386–390.PubMed
129.
Frauscher B, Nomura T, Duerr S, et al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol 2012;259:1056–1061.
130.
Ferini-Strambi L. Does idiopathic REM sleep behavior disorder (iRBD) really exist? What are the potential markers of neurodegeneration in iRBD? Sleep Med 2011;12(suppl 2):S43-S49.PubMed
131.
Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020–1025.PubMed
132.
Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 2006;67:2236–2238.PubMed
133.
Miyamoto T, Miyamoto M, Suzuki K, Nishibayashi M, Iwanami M, Hirata K. 123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder. Sleep 2008;31:717–723.PubMed
134.
Schenkel E, Siegel JM. REM sleep without atonia after lesions of the medial medulla. Neurosci Lett 1989;98:159–165.PubMed
135.
Fort P, Rampon C, Gervasoni D, Peyron C, Luppi PH. Anatomical demonstration of a medullary enkephalinergic pathway potentially implicated in the oro-facial muscle atonia of paradoxical sleep in the cat. Sleep Res Online 1998;1:102–108.PubMed
136.
Brooks PL, Peever JH. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J Neurosci 2011;31:7111–7121.PubMed
137.
Verhave PS, Jongsma MJ, Van den Berg RM, et al. REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease. Sleep 2011;34:1119–1125.PubMed
138.
Schenck CH, Mahowald MW. REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002;25:120–138.PubMed
139.
Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5:572–577.PubMed
140.
Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009;72:1296–1300.PubMed
141.
Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000;123:1155–1160.PubMed
142.
Eisensehr I, Linke R, Tatsch K, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003;26:507–512.PubMed
143.
Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000;55:1410–1412.PubMed
144.
Iranzo A, Valldeoriola F, Lomena F, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2011;10:797–805.PubMed
145.
Miyamoto M, Miyamoto T, Iwanami M, et al. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder. Sleep Med 2012;13:102–106.PubMed
146.
Scherfler C, Frauscher B, Schocke M, et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann Neurol 2011;69:400–407.PubMed
147.
Kumru H, Santamaria J, Tolosa E, et al. Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations. Ann Neurol 2004;56:599–603.PubMed
148.
Mahowald MW, Schenck CH. The REM sleep behavior disorder odyssey. Sleep Med Rev 2009;13:381–384.PubMed
149.
Arnulf I, Merino-Andreu M, Bloch F, et al. REM sleep behavior disorder and REM sleep without atonia in patients with progressive supranuclear palsy. Sleep 2005;28:349–354.PubMed
150.
De Cock VC, Lannuzel A, Verhaeghe S, et al. REM sleep behavior disorder in patients with guadeloupean parkinsonism, a tauopathy. Sleep 2007;30:1026–1032.PubMed
151.
Nomura T, Inoue Y, Takigawa H, Nakashima K. Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease. Parkinsonism Relat Disord 2012;18:394–396.PubMed
152.
Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E. REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci 2012;33:371–373.PubMed
153.
Schenck CH, Garcia-Rill E, Skinner RD, Anderson ML, Mahowald MW. A case of REM sleep behavior disorder with autopsy-confirmed Alzheimer's disease: postmortem brain stem histochemical analyses. Biol Psychiatry 1996;40:422–425.PubMed
154.
Fukutake T, Shinotoh H, Nishino H, et al. Homozygous Machado-Joseph disease presenting as REM sleep behaviour disorder and prominent psychiatric symptoms. Eur J Neurol 2002;9:97–100.PubMed
155.
Friedman JH. Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3). Mov Disord 2002;17:1350–1353.PubMed
156.
Syed BH, Rye DB, Singh G. REM sleep behavior disorder and SCA-3 (Machado-Joseph disease). Neurology 2003;60:148.PubMed
157.
Iranzo A, Munoz E, Santamaria J, Vilaseca I, Mila M, Tolosa E. REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease. Mov Disord 2003;18:1179–1183.PubMed
158.
Arnulf I, Nielsen J, Lohmann E, et al. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol 2008;65:482–488.PubMed
159.
Schenck CH, Mahowald MW. Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder. Ann Neurol 1992;32:3–10.PubMed
160.
Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med 2005;6:253–258.PubMed
161.
Nevsimalova S, Prihodova I, Kemlink D, Lin L, Mignot E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med 2007;8:784–786.PubMed
162.
Hoque R, Chesson AL Jr. Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 2010;6:79–83.PubMed
163.
Ju YE, Larson-Prior L, Duntley S. RBD and antidepressants. Sleep Med 2012;13:211–212.PubMed
164.
Guilleminault C, Raynal D, Takahashi S, Carskadon M, Dement W. Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 1976;54:71–87.PubMed
165.
Bental E, Lavie P, Sharf B. Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Isr J Med Sci 1979;15:607–609.PubMed
166.
Mahowald MW, Schenck CH, Bornemann MA. Pathophysiologic mechanisms in REM sleep behavior disorder. Curr Neurol Neurosci Rep 2007;7:167–172.PubMed
167.
Teman PT, Tippmann-Peikert M, Silber MH, Slocumb NL, Auger RR. Idiopathic rapid-eye-movement sleep disorder: associations with antidepressants, psychiatric diagnoses, and other factors, in relation to age of onset. Sleep Med 2009;10:60–65.PubMed
168.
Kimura K, Tachibana N, Kohyama J, Otsuka Y, Fukazawa S, Waki R. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology 2000;55:894–895.PubMed
169.
Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 2006;66:1277–1279.PubMed
170.
Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130:2770–2788.PubMed
171.
Gomez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler 2007;13:805–808.PubMed
172.
Verma A, Anand V, Verma NP. Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 2007;3:357–362.PubMed
173.
Xi Z, Luning W. REM sleep behavior disorder in a patient with pontine stroke. Sleep Med 2009;10:143–146.PubMed
174.
Reynolds TQ, Roy A. Isolated cataplexy and REM sleep behavior disorder after pontine stroke. J Clin Sleep Med 2011;7:211–213.PubMed
175.
Manni R, Ratti PL, Terzaghi M. Secondary ''incidental'' REM sleep behavior disorder: do we ever think of it? Sleep Med 2011;12(suppl 2):S50-S53.PubMed
176.
Snyder S. Isolated sleep paralysis after rapid time-zone change (“jet-lag”) syndrome. Chronobiologia 1983;10:377–379.PubMed
177.
Munezawa T, Kaneita Y, Osaki Y, et al. Nightmare and sleep paralysis among Japanese adolescents: a nationwide representative survey. Sleep Med 2011;12:56–64.PubMed
178.
Cheyne JA. Situational factors affecting sleep paralysis and associated hallucinations: position and timing effects. J Sleep Res 2002;11:169–177.PubMed
179.
Sharpless BA, Barber JP. Lifetime prevalence rates of sleep paralysis: a systematic review. Sleep Med Rev 2011;15:311–315.PubMed
180.
Kompanje EJ. “The devil lay upon her and held her down.” Hypnagogic hallucinations and sleep paralysis described by the Dutch physician Isbrand van Diemerbroeck (1609–1674) in 1664. J Sleep Res 2008;17:464–467.PubMed
181.
Jimenez-Genchi A, Avila-Rodriguez VM, Sanchez-Rojas F, Terrez BE, Nenclares-Portocarrero A. Sleep paralysis in adolescents: the “a dead body climbed on top of me” phenomenon in Mexico. Psychiatry Clin Neurosci 2009;63:546–549.PubMed
182.
Tassinari CA, Rubboli G, Gardella E, et al. Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci 2005;26(suppl 3):s225-s232.PubMed
183.
Tassinari CA, Cantalupo G, Hogl B, et al. Neuroethological approach to frontolimbic epileptic seizures and parasomnias: The same central pattern generators for the same behaviours. Rev Neurol (Paris) 2009;165:762–768.
184.
Luria A. The Working Brain. London: Penguin, 1973.
185.
Broughton RJ. Sleep disorders: disorders of arousal? Enuresis, somnambulism, and nightmares occur in confusional states of arousal, not in "dreaming sleep." Science 1968;159:1070–1078.PubMed
186.
Braun AR, Balkin TJ, Wesenten NJ, et al. Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 1997;120:1173–1197.PubMed
187.
Juszczak GR, Swiergiel AH. Serotonergic hypothesis of sleepwalking. Med Hypotheses 2005;64:28–32.PubMed
188.
189.
Lillywhite AR, Wilson SJ, Nutt DJ. Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry 1994;164:551–554.PubMed
190.
Wilson SJ, Lillywhite AR, Potokar JP, Bell CJ, Nutt DJ. Adult night terrors and paroxetine. Lancet 1997;350:185.PubMed
191.
Jacobs BL, Martin-Cora FJ, Fornal CA. Activity of medullary serotonergic neurons in freely moving animals. Brain Res Brain Res Rev 2002;40:45–52.PubMed
192.
Rekling JC, Funk GD, Bayliss DA, Dong XW, Feldman JL. Synaptic control of motoneuronal excitability. Physiol Rev 2000;80:767–852.PubMed
193.
Steinfels GF, Heym J, Strecker RE, Jacobs BL. Behavioral correlates of dopaminergic unit activity in freely moving cats. Brain Res 1983;258:217–228.PubMed
194.
Richerson GB, Wang W, Tiwari J, Bradley SR. Chemosensitivity of serotonergic neurons in the rostral ventral medulla. Respir Physiol 2001;129:175–189.PubMed
195.
Arkin A. Night-Terrors as Anomalous REM sleep component manifestation in slow-wave sleep. Waking Sleeping 1978;2:143–147.
196.
Bell C, Wilson S, Rich A, Bailey J, Nutt D. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology (Berl) 2003;166:102–110.
197.
Wills L, Garcia J. Parasomnias: epidemiology and management. CNS Drugs 2002;16:803–810.PubMed
198.
Mahowald MW, Schenck CH. Non-rapid eye movement sleep parasomnias. Neurol Clin 2005;23:1077–1106.PubMed
199.
Kushida CA, Clerk AA, Kirsch CM, Hotson JR, Guilleminault C. Prolonged confusion with nocturnal wandering arising from NREM and REM sleep: a case report. Sleep 1995;18:757–764.PubMed
200.
Alves R, Aloe F, Tavares S. Sexual behavior in sleep, sleepwalking, and possible REM behavior disorder: a case report. Sleep ResOnline 1999;2:71–72.
201.
Walters AS, Lavigne G, Hening W, Picchietti DL, Allen RP, Chokroverty S, et al. The scoring of movements in sleep. J Clin Sleep Med 2007;3:155–167.PubMed
202.
Neikrug AB, Ancoli-Israel S. Diagnostic tools for REM sleep behavior disorder. Sleep Med Rev 2012;16:415–429.
203.
Edinger JD, Fins AI, Sullivan RJ Jr, et al. Sleep in the laboratory and sleep at home: comparisons of older insomniacs and normal sleepers. Sleep 1997;20:1119–1126.PubMed
204.
Zhang J, Lam SP, Ho CK, et al. Diagnosis of REM sleep behavior disorder by video-polysomnographic study: is one night enough? Sleep 2008;31:1179–1185.PubMed
205.
Consens FB, Chervin RD, Koeppe RA, et al. Validation of a polysomnographic score for REM sleep behavior disorder. Sleep 2005;28:993–997.PubMed
206.
Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias. Neurol Clin 2005;23:1107–1126.PubMed
207.
Oudiette D, Leu-Semenescu S, Roze E, et al. A motor signature of REM sleep behavior disorder. Mov Disord 2012;27:428–431.PubMed
208.
Oudiette D, Leclair-Visonneau L, Arnulf I. Video-clinical corners. Snoring, penile erection and loss of reflexive consciousness during REM sleep behavior disorder. Sleep Med 2010;11:953–955.PubMed
209.
Takeuchi T, Miyasita A, Sasaki Y, Inugami M, Fukuda K. Isolated sleep paralysis elicited by sleep interruption. Sleep 1992;15:217–225.PubMed
210.
Howell MJ, Arneson PA, Schenck CH. A novel therapy for REM sleep behavior disorder (RBD). J Clin Sleep Med 2011;7:639-644A.PubMed
211.
Satija P, Ondo WG. Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 2008;22:497–518.PubMed
212.
Barion A, Zee PC. A clinical approach to circadian rhythm sleep disorders. Sleep Med 2007;8:566–577.PubMed
213.
Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006;295:2851–2858.PubMed
214.
Harris M, Grunstein RR. Treatments for somnambulism in adults: assessing the evidence. Sleep Med Rev 2009;13:295–297.PubMed
215.
Rudolph U, Mohler H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 2006;6:18–23.PubMed
216.
Schenck CH, Mahowald MW. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med 1996;100:333–337.PubMed
217.
Kavey NB, Whyte J, Resor SR Jr, Gidro-Frank S. Somnambulism in adults. Neurology 1990;40:749–752.PubMed
218.
Cooper AJ. Treatment of coexistent night-terrors and somnambulism in adults with imipramine and diazepam. J Clin Psychiatry 1987;48:209–210.PubMed
219.
Balon R. Sleep terror disorder and insomnia treated with trazodone: a case report. Ann Clin Psychiatry 1994;6:161–163.PubMed
220.
Reid WH, Haffke EA, Chu CC. Diazepam in intractable sleepwalking: a pilot study. Hillside J Clin Psychiatry 1984;6:49–55.PubMed
221.
Schenck CH, Boyd JL, Mahowald MW. A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep 1997;20:972–981.PubMed
222.
Hurwitz TD, Mahowald MW, Schenck CH, Schluter JL, Bundlie SR. A retrospective outcome study and review of hypnosis as treatment of adults with sleepwalking and sleep terror. J Nerv Ment Dis 1991;179:228–233.PubMed
223.
Hauri PJ, Silber MH, Boeve BF. The treatment of parasomnias with hypnosis: a 5-year follow-up study. J Clin Sleep Med 2007;3:369–373.PubMed
224.
Tobin JD Jr. Treatment of somnambulism with anticipatory awakening. J Pediatr 1993;122:426–427.PubMed
225.
Frank NC, Spirito A, Stark L, Owens-Stively J. The use of scheduled awakenings to eliminate childhood sleepwalking. J Pediatr Psychol 1997;22:345–353.PubMed
226.
Schenck CH, Hurwitz TD, O'Connor KA, Mahowald MW. Additional categories of sleep-related eating disorders and the current status of treatment. Sleep 1993;16:457–466.PubMed
227.
Winkelman JW. Treatment of nocturnal eating syndrome and sleep-related eating disorder with topiramate. Sleep Med 2003;4:243–246.PubMed
228.
Schenck CH MM. Topiramate therapy of sleep related eating disorder (SRED). Sleep 2006;29:a268.
229.
Winkelman JW. Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry 2006;67:1729–1734.PubMed
230.
Aurora RN, Zak RS, Maganti RK, et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010;6:85–95.PubMed
231.
Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology 2006;67:742–747.PubMed
232.
Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res 2010;19:591–596.PubMed
233.
Seppi K, Weintraub D, Coelho M, et al. The Movement Disorder Society Evidence-Based Medicine Review Update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011;26(suppl 3):S42-S80.PubMed
234.
Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331–339.PubMed
235.
Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992;42:1371–1374.PubMed
236.
Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388–393.PubMed
237.
Gagnon JF, Petit D, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep 2006;29:1321–1325.PubMed
238.
Gugger JJ, Wagner ML. Rapid eye movement sleep behavior disorder. Ann Pharmacother 2007;41:1833–1841.PubMed
239.
Anderson KN, Shneerson JM. Drug treatment of REM sleep behavior disorder: the use of drug therapies other than clonazepam. J Clin Sleep Med 2009;5:235–239.PubMed
240.
Chouinard G. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 2004;65(suppl 5):7–12.PubMed
241.
Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999;14:507–511.PubMed
242.
Takeuchi N, Uchimura N, Hashizume Y, Mukai M, Etoh Y, Yamamoto K, et al. Melatonin therapy for REM sleep behavior disorder. Psychiatry Clin Neurosci 2001;55:267–269.PubMed
243.
Boeve BF, Silber MH, Ferman TJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003;4:281–284.PubMed
244.
Arnulf I, Bejjani BP, Garma L, et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000;55:1732–1734.PubMed
245.
Iranzo A, Valldeoriola F, Santamaria J, Tolosa E, Rumia J. Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:661–664.PubMed
246.
Cicolin A, Lopiano L, Zibetti M, et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med 2004;5:207–210.PubMed
247.
Hamani C, Moro E, Lozano AM. The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm 2011;118:1461–1468.PubMed
248.
Jones BE. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 1991;40:637–656.PubMed
249.
Hobson JA. REM sleep and dreaming: towards a theory of protoconsciousness. Nat Rev Neurosci 2009;10:803–813.PubMed
250.
Atienza M, Cantero JL. Complex sound processing during human REM sleep by recovering information from long-term memory as revealed by the mismatch negativity (MMN). Brain Res 2001;901:151–160.PubMed
251.
Snyder S, Hams G. Serotoninergic agents in the treatment of isolated sleep paralysis. Am J Psychiatry 1982;139:1202–1203.PubMed
252.
Koran LM, Raghavan S. Fluoxetine for isolated sleep paralysis. Psychosomatics 1993;34:184–187.PubMed
Metadata
Title
Parasomnias: An Updated Review
Author
Michael J. Howell
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Neurotherapeutics / Issue 4/2012
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-012-0143-8

Other articles of this Issue 4/2012

Neurotherapeutics 4/2012 Go to the issue

ReviewPaper

New and Unconventional Treatments for Obstructive Sleep Apnea

ReviewPaper

Current Treatment of Selected Pediatric Sleep Disorders

EditorialNotes

Editorial

Original Article

Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model

ReviewPaper

Strategies for the Treatment of Restless Legs Syndrome

ReviewPaper

Classification of Sleep Disorders